
[ Thu, Apr 26th 2018 ]: WOPRAI
[ Thu, Apr 26th 2018 ]: WOPRAI
[ Thu, Apr 26th 2018 ]: WOPRAI
[ Thu, Apr 26th 2018 ]: WOPRAI
[ Thu, Apr 26th 2018 ]: WOPRAI
[ Thu, Apr 26th 2018 ]: WOPRAI

[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI

[ Tue, Apr 24th 2018 ]: WOPRAI
[ Tue, Apr 24th 2018 ]: WOPRAI
[ Tue, Apr 24th 2018 ]: WOPRAI
[ Tue, Apr 24th 2018 ]: WOPRAI
[ Tue, Apr 24th 2018 ]: WOPRAI
[ Tue, Apr 24th 2018 ]: WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $369 on, Apr 25th, 2018


🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $365 to $369 on, Apr 25th, 2018.
Matthew has made no other calls on BIIB in the last 4 months.
There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoff Meacham of "Barclays" Downgraded from Buy to Hold on, Thursday, April 5th, 2018
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $350 on, Wednesday, January 24th, 2018
These are the ratings of the 5 analyists that currently disagree with Matthew
- Ian Somaiya of "BMO Capital" Maintained at Buy with Decreased Target to $393 on, Monday, March 5th, 2018
- Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $433 on, Monday, February 5th, 2018
- Carter Gould of "UBS" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $363 on, Friday, January 26th, 2018
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Friday, January 26th, 2018
Similar Stocks and Investing Publications
[ Thu, Apr 05th 2018 ]: WOPRAI
[ Mon, Mar 05th 2018 ]: WOPRAI
[ Mon, Feb 05th 2018 ]: WOPRAI
[ Wed, Jan 31st 2018 ]: WOPRAI
[ Fri, Jan 26th 2018 ]: WOPRAI
[ Fri, Jan 26th 2018 ]: WOPRAI
[ Wed, Jan 24th 2018 ]: WOPRAI
[ Thu, Nov 09th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Fri, Oct 27th 2017 ]: WOPRAI
[ Tue, Apr 09th 2013 ]: WOPRAI
[ Thu, Apr 04th 2013 ]: WOPRAI